google-site-verification: googlec7193c3de77668c9.html

Myeloma care still lacking practical tools to personalize treatment, study finds

[
Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited tools at their disposal to predict who is most likely to benefit or suffer from a particular myeloma therapy. These findings are reported in a recent study published in the European Journal of Haematology, in which the authors present a comprehensive review of the field. The study maps the current approaches to prediction in multiple myeloma, highlighting what is missing and outlining the path forward for truly personalized care of cancer patients.


Source link

Advertisements
Views: 0

See also  Promising immunotherapy treatment targets multiple pathogenic hallmarks of Alzheimer's disease

Check Also

People who use illicit fentanyl consume daily doses equivalent to nearly 9,000 mg of morphine, study finds

[ Model Parameters: Fentanyl Consumption, Percent Concentration (Purity), and MME Equivalence. Credit: Drug and Alcohol …

What's really going on in your gut?

The gut is home to around trillions of microorganisms, including bacteria, viruses and fungi. What …

Nearly 3,000 patients a day face corridor care in NHS

New data reveals sheer scale of patients in England being treated in unsafe and undignified …

Leave a Reply

Available for Amazon Prime
heavy equipment transport allegheny pa.